Global Core Electronic Medicinal Product Information (ePI), published by HL7 International - Biomedical Research & Regulation Work Group. This guide is not an authorized publication; it is the continuous build for version 1.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/emedicinal-product-info/ and changes regularly. See the Directory of published versions
Last updated: 2025-12-11 02:21:13+0000; Language: en
Bundle 8ca935a2-79e9-445b-a38c-f5ce4253f3f5 of type searchset
Entry 1 - fullUrl = http://sandbox.hl7europe.eu/unicom/fhir/MedicinalProductDefinition/Betaklav-500mg-125mg-EE-MPD
Search:Mode = match
Resource MedicinalProductDefinition:
version: 1; Last updated: 2025-11-26 10:51:48+0000; Language: en
Profile:
http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinitionidentifier:
http://ema.europa.eu/fhir/mpId/EE-100009540-30722,http://ema.europa.eu/fhir/pmsId/0000000000006domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Film-coated tablet
legalStatusOfSupply: Medicinal Product subject to medical prescription
classification: amoxicillin and beta-lactamase inhibitor, amoxicillin and beta-lactamase inhibitor
name
productName: Betaklav 500 mg/125 mg õhukese polümeerikattega tabletid
part
part: Betaklav
type: Invented name part
part
part: 500mg/125mg
type: Strength part
part
part: õhukese polümeerikattega tabletid
type: Pharmaceutical dose form part
Usages
Country Language Republic of Estonia Estonian
Entry 2 - fullUrl = http://sandbox.hl7europe.eu/unicom/fhir/RegulatedAuthorization/Betaklav-500mg-125mg-EE-RA
Search:Mode = include
Resource RegulatedAuthorization:
version: 1; Last updated: 2025-11-26 10:51:49+0000; Language: en
Profile:
http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorizationidentifier: 879415
type: Marketing Authorisation
region: Republic of Estonia
status: Valid - Renewed/Varied
statusDate: 2021-02-03
Entry 3 - fullUrl = http://sandbox.hl7europe.eu/unicom/fhir/PackagedProductDefinition/Betaklav-500mg-125mg-EE-PPD-1635117
Search:Mode = include
Resource PackagedProductDefinition:
version: 1; Last updated: 2025-11-26 10:51:50+0000; Language: en
Profile:
http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinitionidentifier:
http://ema.europa.eu/example/pcid/EE-100009540-30722-1635117containedItemQuantity: 10 tablet (Details: 200000000014 code200000002152 = '200000002152')
description:
Ribapakend (Al/Al) 10 õhukese polümeerikattega tabletti karbis
MarketingStatuses
Country Status Republic of Estonia Marketed packaging
type: Box
quantity: 1
material: Cardboard
packaging
type: Strip
quantity: 1
material: Aluminium
containedItem
Items
Reference ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = Tablet amount: 10
Entry 4 - fullUrl = http://sandbox.hl7europe.eu/unicom/fhir/PackagedProductDefinition/Betaklav-500mg-125mg-EE-PPD-1635207
Search:Mode = include
Resource PackagedProductDefinition:
version: 1; Last updated: 2025-11-26 10:51:50+0000; Language: en
Profile:
http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinitionidentifier:
http://ema.europa.eu/example/pcid/EE-100009540-30722-1635207containedItemQuantity: 500 tablet (Details: 200000000014 code200000002152 = '200000002152')
description:
Ribapakend (Al/Al) 500 õhukese polümeerikattega tabletti karbis
MarketingStatuses
Country Status Republic of Estonia Marketed packaging
type: Box
quantity: 1
material: Cardboard
packaging
type: Strip
quantity: 1
material: Aluminium
containedItem
Items
Reference ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = Tablet amount: 500
Entry 5 - fullUrl = http://sandbox.hl7europe.eu/unicom/fhir/PackagedProductDefinition/Betaklav-500mg-125mg-EE-PPD-1635139
Search:Mode = include
Resource PackagedProductDefinition:
version: 1; Last updated: 2025-11-26 10:51:51+0000; Language: en
Profile:
http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinitionidentifier:
http://ema.europa.eu/example/pcid/EE-100009540-30722-1635139containedItemQuantity: 14 tablet (Details: 200000000014 code200000002152 = '200000002152')
description:
Blisterpakend (OPA/Al/PVC foil/Al foil) 14 õhukese polümeerikattega tabletti karbis
MarketingStatuses
Country Status Republic of Estonia Marketed packaging
type: Box
quantity: 1
material: Cardboard
packaging
type: Blister
quantity: 1
material: Orientated PolyAmide, Aluminium, PolyVinyl Chloride
containedItem
Items
Reference ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = Tablet amount: 14
Entry 6 - fullUrl = http://sandbox.hl7europe.eu/unicom/fhir/AdministrableProductDefinition/Betaklav-500mg-125mg-EE-APD
Search:Mode = include
Resource AdministrableProductDefinition:
version: 1; Last updated: 2025-11-26 10:53:25+0000; Language: en
Profile:
http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinitionstatus: Active
administrableDoseForm: Film-coated tablet
unitOfPresentation: Tablet
producedFrom: ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = Tablet
RouteOfAdministrations
Code Oral use
Entry 7 - fullUrl = http://sandbox.hl7europe.eu/unicom/fhir/Ingredient/Betaklav-500mg-125mg-EE-I-100000092629
Search:Mode = include
Resource Ingredient:
version: 1; Last updated: 2025-11-26 10:53:25+0000; Language: en
Profile:
http://unicom-project.eu/fhir/StructureDefinition/PPLIngredientstatus: Active
for:
- MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#EE-100009540-30722,http://ema.europa.eu/fhir/pmsId#0000000000006; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; legalStatusOfSupply = Medicinal Product subject to medical prescription; classification = amoxicillin and beta-lactamase inhibitor,amoxicillin and beta-lactamase inhibitor
- ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = Tablet
- AdministrableProductDefinition: status = active; administrableDoseForm = Film-coated tablet; unitOfPresentation = Tablet
role: Active
substance
Codes
Concept AMOXICILLIN TRIHYDRATE strength
presentation: 573.892 milligram(s) (Details: 100000110633 code100000110655 = '100000110655')/1 tablet (Details: 200000000014 code200000002152 = '200000002152')
referenceStrength
Substances
Concept Amoxicillin strength: 500 milligram(s) (Details: 100000110633 code100000110655 = '100000110655')/1 tablet (Details: 200000000014 code200000002152 = '200000002152')
Entry 8 - fullUrl = http://sandbox.hl7europe.eu/unicom/fhir/Ingredient/Betaklav-500mg-125mg-EE-I-100000093061
Search:Mode = include
Resource Ingredient:
version: 1; Last updated: 2025-11-26 10:53:26+0000; Language: en
Profile:
http://unicom-project.eu/fhir/StructureDefinition/PPLIngredientstatus: Active
for:
- MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#EE-100009540-30722,http://ema.europa.eu/fhir/pmsId#0000000000006; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; legalStatusOfSupply = Medicinal Product subject to medical prescription; classification = amoxicillin and beta-lactamase inhibitor,amoxicillin and beta-lactamase inhibitor
- ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = Tablet
- AdministrableProductDefinition: status = active; administrableDoseForm = Film-coated tablet; unitOfPresentation = Tablet
role: Active
substance
Codes
Concept POTASSIUM CLAVULANATE strength
presentation: 151.915 milligram(s) (Details: 100000110633 code100000110655 = '100000110655')/1 tablet (Details: 200000000014 code200000002152 = '200000002152')
referenceStrength
Substances
Concept CLAVULANIC ACID strength: 125 milligram(s) (Details: 100000110633 code100000110655 = '100000110655')/1 tablet (Details: 200000000014 code200000002152 = '200000002152')
Entry 9 - fullUrl = http://sandbox.hl7europe.eu/unicom/fhir/ManufacturedItemDefinition/Betaklav-500mg-125mg-EE-MID
Search:Mode = include
Resource ManufacturedItemDefinition:
version: 1; Last updated: 2025-11-26 10:51:49+0000; Language: en
Profile:
http://unicom-project.eu/fhir/StructureDefinition/PPLManufacturedItemDefinitionstatus: Active
manufacturedDoseForm: Film-coated tablet
unitOfPresentation: Tablet
Entry 10 - fullUrl = http://sandbox.hl7europe.eu/unicom/fhir/Organization/LOC-100009540-KrkaNovoMesto
Search:Mode = include
Resource Organization:
version: 1; Last updated: 2025-11-26 10:50:40+0000; Language: en
Profile:
http://unicom-project.eu/fhir/StructureDefinition/PPLOrganizationidentifier:
https://spor.ema.europa.eu/v1/locations/LOC-100009540,https://spor.ema.europa.eu/v1/organisations/ORG-100000627name: KRKA, d.d., Novo mesto